All News
|
Research Feature
Cardiovascular disease remains the leading cause of death worldwide. This is why Nicole Redmond, M.D., Ph.D., M.P.H., chief of the Clinical Applications and Prevention branch in NHLBI’s Division of Cardiovascular Sciences, is bringing attention to silent pieces of information, like elevated blood pressure or cholesterol. When they go unchecked...
Showing 10 out of 283 results
|
News Release
Large NIH-supported study showed that rural-dwelling Black men are at greatest risk Adults living in rural areas of the United States have a 19% higher risk of developing heart failure compared to their urban counterparts, and Black men living in rural areas have an especially higher risk – 34%, according to a large observational study supported by...
|
Statement
Findings from a randomized, non-blinded, phase 3 clinical trial supported by the National Institutes of Health found no significant difference in 90-day mortality rates, nor safety concerns, after providing patients with one of two common treatment strategies for sepsis. The findings were published in the New England Journal of Medicine and were...
|
News Release
NIH-funded clinical trial underscores need for better treatments for deadly condition Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The...
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces new director of its Division of Blood Diseases and Resources WHO: Julie Panepinto, M.D., MSPH WHEN: Dr. Panepinto will start her new NHLBI position on January 15, 2023. WHERE: NHLBI of the National Institutes of Health BRIEF BIOGRAPHY: Dr. Julie Panepinto, a pediatric...
|
News Release
NIH-supported study finds no serious complications following rare immune condition A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence. About half of participants experienced...
|
Media Availability
WHAT: Two National Institute of Health-supported diets, Dietary Approaches to Stop Hypertension (DASH) and Therapeutic Lifestyle Changes (TLC), together earned five No. 1 spots in U.S. News & World Report’s 2023 “Best Diets” rankings. The National Heart, Lung, and Blood Institute (NHLBI), part of NIH, researched, developed and tested both diets. Of...
|
News Release
NIH findings may provide early clues about increased risks for advanced biological aging and premature death Adults who stay well-hydrated appear to be healthier, develop fewer chronic conditions, such as heart and lung disease, and live longer than those who may not get sufficient fluids, according to a National Institutes of Health study...
|
News Release
Lower levels of HDL cholesterol were associated with increased risks for heart attacks in white but not Black adults, and higher levels were not protective for either group A National Institutes of Health-supported study found that high-density lipoprotein (HDL) cholesterol, often called the “good cholesterol,” may not be as effective as scientists...
|
News Release
Certain adults with this artery-blocking condition may see more benefits with an open bypass compared to less-invasive procedures to improve circulation Performing open bypass surgery to restore circulation for people with a severe form of peripheral artery disease (PAD) – a condition that limits blood flow to the legs and feet – resulted in better...
|
News Release
Telemedicine, home-monitoring may have helped lessen impact Adults with hypertension saw a small, but consequential, rise in their blood pressure levels during the first eight months of the COVID-19 pandemic, while the number of times they had their blood pressure measured dropped significantly, according to a study supported by the National...